CEBP CTRC-AACR San Antonio Breast Cancer Symposium 2008 Conference on Cancer Prevention - Washington, D.C.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Wrensch, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Wrensch, M.

Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 4 303-308, Copyright © 1998 by American Association for Cancer Research


ARTICLES

p53 mutations in malignant gliomas

Y Li, RC Millikan, S Carozza, B Newman, E Liu, R Davis, R Miike and M Wrensch
Department of Epidemiology, School of Public Health, University of North Carolina, Chapel Hill 27599-7400, USA.

A population-based series of incident cases of malignant glioma were analyzed for mutations in the tumor suppressor gene p53. Exons 4-8 were screened using PCR-single-strand conformation analysis and confirmed through direct sequencing. Of 62 tumors analyzed, 12 (19%) contained mutations in p53: one 18-bp duplication in exon 5, five point mutations in exon 4, three point mutations in exon 7, two point mutations in exon 8, and a splice-site mutation at the exon 6/intron 7 boundary. In contrast to previous studies of malignant glioma, the prevalence of transversion mutations (56%) was higher than transition mutations (33%). A large proportion of transversion mutations occurred in exon 4, a region that is not routinely screened in gliomas. We present here an improved method for screening exon 4 (and other GC-rich regions) of p53 using PCR-single-strand conformation analysis. The high frequency of transversion mutations suggests a role for exogenous carcinogens in the etiology of malignant glioma.


This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. E. Scheurer, C. J. Etzel, M. Liu, R. El-Zein, G. E. Airewele, B. Malmer, K. D. Aldape, J. S. Weinberg, W.K. A. Yung, and M. L. Bondy
Aggregation of Cancer in First-Degree Relatives of Patients with Glioma
Cancer Epidemiol. Biomarkers Prev., November 1, 2007; 16(11): 2491 - 2495.
[Abstract] [Full Text] [PDF]


Home page
Neuro OncolHome page
M. Wrensch, Y. Minn, T. Chew, M. Bondy, and M. S. Berger
Epidemiology of primary brain tumors: Current concepts and review of the literature
Neuro-oncol, October 1, 2002; 4(4): 278 - 299.
[Abstract] [PDF]


Home page
Cancer Res.Home page
K. Conway, S. N. Edmiston, L. Cui, S. S. Drouin, J. Pang, M. He, C.-K. Tse, J. Geradts, L. Dressler, E. T. Liu, et al.
Prevalence and Spectrum of p53 Mutations Associated with Smoking in Breast Cancer
Cancer Res., April 1, 2002; 62(7): 1987 - 1995.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
A. Chakravarti, M. A. Delaney, E. Noll, P. McL. Black, J. S. Loeffler, A. Muzikansky, and N. J. Dyson
Prognostic and Pathologic Significance of Quantitative Protein Expression Profiling in Human Gliomas
Clin. Cancer Res., August 1, 2001; 7(8): 2387 - 2395.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1998 by the American Association for Cancer Research.